Protective effects of ω-conotoxin on Amyloid-β-induced damage in PC12 cells

Toxicology Letters

Volumn 206, Issue 3, 2011, Pages 325-338

  Fang, Marong ^a   Wang, Jing ^a   Han, Shu ^a   Hu, Zhiying ^b   Zhan, Jin biao ^a   Ling, Shucai ^a   Rudd, John A ^c   Geng, Yu ^d  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Hangzhou Red Cross Hospital   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Cell death; Cytotoxicity; Neuroprotective; Amyloid; Conotoxin

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; OMEGA CONOTOXIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 80053198125     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.07.022     Document Type: Article

References (38)

1. Arispe N., Rojas E., Pollard H.B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:567-571.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
3. Choi S.H., Bosetti F. Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid. Aging 2009, 1:234-244.
4. Crisafulli C., Galuppo M., Cuzzocrea S. Effects of genetic and pharmacological inhibition of TNF-alpha in the regulation of inflammation in macrophages. Pharmacol. Res. 2009, 60:332-340.
5. Chen C.H., Zhou W., Liu S., Deng Y., Cai F., Tone M., Tone Y., Tong Y., Song W. Increased NF-(B signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int. J. Neuropsychopharmacol. 2011, 18:1-14.
6. Dragicevic N., Mamcarz M., Zhu Y., Buzzeo R., Tan J., Arendash G.W., Bradshaw P.C. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J. Alzheimers Dis. 2010, 2:S535-S550.
7. Emre M., Geula C., Ransil B.J., Mesulam M.M. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain. Neurobiol. Aging 1992, 13:553-559.
8. 2+ channel. Eur. J. Pharmacol. 1997, 321:217-223.
9. Hjorth, E., Frenkel, D., Weiner, H., Schultzberg, M., 2010. Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia. Int. J. Alzheimers Dis. [E. Pub.].
10. Koh S.H., Song C., Noh M.Y., Kim H.Y., Lee K.Y., Lee Y.J., Kim J., Kim S.H., Kim H.T. Inhibition of glycogen synthase kinase-3 reduces L-DOPA-induced neurotoxicity. Toxicology 2008, 247:112-118.
11. Jang J.H., Surh Y.J. beta-Amyloid induces oxidative DNA damage and cell death through activation of c-Jun N terminal kinase. Ann. N. Y. Acad. Sci. 2002, 973:228-236.
12. Jang J.H., Surh Y.J. Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radical Biol. Med. 2003, 34:1100-1110.
13. Lin M.C., Kagan B.L. Electrophysiologic properties of channels induced by Abeta 25-35 in planar lipid bilayers. Peptides 2002, 23:1215-1228.
14. Liang X., Wang Q., Hand T., Wu L., Breyer R.M., Montine T.J., Andreasson K. Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. J. Neurosci. 2005, 25:10180-10187.
15. Lee Y.J., Park K.H., Park H.H., Kim Y.J., Lee K.Y., Kim S.H., Koh S.H. Cilnidipine mediates a neuroprotective effect by scavenging free radicals and activating the phosphatidylinositol 3-kinase pathway. J. Neurochem. 2009, 111:90-100.
16. Larsen B.D., Rampalli S., Burns L.E., Brunette S., Dilworth F.J., Megeney L.A. Caspase 3/caspase-activated DNase promote cell differentiation by inducing DNA strand breaks. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:4230-4235.
17. Moechars D., Dewachter I., Lorent K., Reversé D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Haute C.V., Checler F., Godaux E., Cordell B., Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 1999, 274:6483-6492.
18. Mhatre M., Floyd R.A., Hensley K. Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J. Alzheimers Dis. 2004, 6:147-157.
19. Michaelis M.L., Ansar S., Chen Y., Reiff E.R., Seyb K.I., Himes R.H., Audus K.L., Georg G.I. {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents. Pharmacol. Exp. Ther. 2005, 312:659-668.
20. Massote P.D., Pinheiro A.C., Fonseca C.G., Prado M.A., Guimarães A.L., Massensini A.R., Gomez M.V. Protective effect of retinal ischemia by blockers of voltage-dependent calcium channels and intracellular calcium stores. Cell. Mol. Neurobiol. 2008, 28:847-856.
21. Medeiros R., Figueiredo C.P., Pandolfo P., Duarte F.S., Prediger R.D., Passos G.F., Calixto J.B. The role of TNF-alpha signalling pathway on COX-2 upregulation and cognitive decline induced by beta-amyloid peptide. Behav. Brain Res. 2010, 209:165-173.
22. Nakagami Y., Nishimura S., Murasugi T., Kubo T., Kaneko I., Meguro M., Marumoto S., Kogen H., Koyama K., Oda T. A novel compound RS-0466 reverses beta-amyloid-induced cytotoxicity through the Akt signaling pathway in vitro. Eur. J. Pharmacol. 2002, 457:11-17.
23. Nivsarkar M., Banerjee A., Padh H. Cyclooxygenase inhibitors: a novel direction for Alzheimer's management. Pharmacol. Rep. 2008, 60:692-698.
24. Pike C.J., Cummings B.J., Cotman C.W. beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport 1992, 3:769-772.
25. Pringle A.K., Benham C.D., Sim L., Kennedy J., Iannotti F., Sundstrom L.E. Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures. Stroke 1996, 27:2124-2130.
26. Rosales-Corral S., Tan D.X., Reiter R.J., Valdivia-Velázquez M., Acosta-Martínez J.P., Ortiz G.G. Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-beta onto the hippocampus in vivo. J. Neuroimmunol. 2004, 150:20-28.
27. Su J.H., Zhao M., Anderson A.J., Srinivasan A., Cotman C.W. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res. 2001, 898:350-357.
28. Scarpini E., Scheltensb P., Feldmanc H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol. 2003, 2:539-547.
29. Szaingurten-Solodkin I., Hadad N., Levy R. Regulatory role of cytosolic phospholipase A2alpha in NADPH oxidase activity and in inducible nitric oxide synthase induction by aggregated Abeta1-42 in microglia. Glia 2009, 57:1727-1740.
30. Twede V.D., Miljanich G., Olivera B.M., Bulaj G. Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads. Curr. Opin. Drug Discov. Dev. 2009, 12:231-239.
31. Van Dam D., De Deyn P.P. Drug discovery in dementia: the role of rodent models. Nat. Rev. Drug Discov. 2006, 5:956-970.
32. Wang H., Joseph J.A. Mechanisms of hydrogen peroxide-induced calcium dysregulation in PC12 cells. Free Radical Biol. Med. 2000, 28:1222-1231.
33. Wang D., Noda Y., Zhou Y., Mouri A., Mizoguchi H., Nitta A., Chen W., Nabeshima T. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems. Neuropsychopharmacology 2007, 32:1261-1271.
34. Wu K.L., Hsu C., Chan J.Y. Impairment of the mitochondrial respiratory enzyme activity triggers sequential activation of apoptosis-inducing factor-dependent and caspase-dependent signaling pathways to induce apoptosis after spinal cord injury. Neurochemistry 2007, 101:1552-1566.
35. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 1990, 250:279-282.
36. Yan S.D., Zhu H., Fu J., Yan S.F., Roher A., Tourtellotte W.W., Rajavashisth T., Chen X., Godman G.C., Stern D., Schmidt A.M. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:5296-5301.
37. Yuyama K., Yamamoto H., Nishizaki I., Kato T., Sora I., Yamamoto T. Caspase-independent cell death by low concentrations of nitric oxide in PC12 cells: involvement of cytochrome C oxidase inhibition and the production of reactive oxygen species in mitochondria. J. Neurosci. Res. 2003, 73:351-363.
38. Yuan W., Guo J., Li X., Zou Z., Chen G., Sun J., Wang T., Lu D. Hydrogen peroxide induces the activation of the phospholipase C-gamma1 survival pathway in PC12 cells: protective role in apoptosis. Acta Biochim. Biophys. Sin. 2009, 41:625-630.